8-K
Current Report
C4 Therapeutics, Inc. Filed Acc 0001628280-26-024336
Material agreement · Regulation FD disclosure
- Item 1.01 Entry into a material definitive agreement
- Item 7.01 Regulation FD disclosure
From the SEC's structured data for this filing
Loading cccc-20260409.htm…